Oak Street Health, Inc.
OSH was delisted on the 1st of May, 2023.
107 hedge funds and large institutions have $8.5B invested in Oak Street Health, Inc. in 2020 Q3 according to their latest regulatory filings, with 107 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GA
General Atlantic
New York
|
+$3.41B |
| 2 |
NP
Newlight Partners
New York
|
+$2.25B |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$483M |
| 4 |
BlackRock
New York
|
+$165M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$119M |
Top Sellers
OSH Hedge Fund Activity: Q3 2020 in Review
107 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Oak Street Health, Inc. (OSH) for Q3 2020, worth a combined $8.5B.
Buyers outnumbered sellers: 107 funds opened new OSH positions and 0 closed out — a net gain of 107 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was General Atlantic, opening a new position worth an estimated $3.41B.
- 107 institutional investors held Oak Street Health, Inc. (OSH) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $8.5B of Oak Street Health, Inc. stock for Q3 2020.
- 107 funds opened new Oak Street Health, Inc. positions in Q3 2020 and 0 closed out, a net change of +107 holders.
- The largest Oak Street Health, Inc. buyer in Q3 2020 was General Atlantic, an estimated $3.41B added.
Based on aggregated 13F filings for Q3 2020.